These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9055382)

  • 21. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
    Morris DJ; Latif SA; Hardy MP; Brem AS
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):161-8. PubMed ID: 17459698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metyrapone is a competitive inhibitor of 11beta-hydroxysteroid dehydrogenase type 1 reductase.
    Sampath-Kumar R; Yu M; Khalil MW; Yang K
    J Steroid Biochem Mol Biol; 1997 Jun; 62(2-3):195-9. PubMed ID: 9393954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovine 11 beta-hydroxysteroid dehydrogenase: from gene to function.
    Yang K
    Endocr Res; 1995; 21(1-2):367-77. PubMed ID: 7588400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for isoforms of 11 beta-hydroxysteroid dehydrogenase in the liver and kidney of the guinea pig.
    Quinkler M; Kosmale B; Bähr V; Oelkers W; Diederich S
    J Endocrinol; 1997 May; 153(2):291-8. PubMed ID: 9166119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
    Whorwood CB; Stewart PM
    J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of 11 beta-hydroxysteroid dehydrogenase type 1 in primary cultures of rat and human hepatocytes.
    Ricketts ML; Shoesmith KJ; Hewison M; Strain A; Eggo MC; Stewart PM
    J Endocrinol; 1998 Jan; 156(1):159-68. PubMed ID: 9496245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of sodium-potassium adenosine triphosphate subunit gene expression by corticosteroids and 11 beta-hydroxysteroid dehydrogenase activity.
    Whorwood CB; Ricketts ML; Stewart PM
    Endocrinology; 1994 Sep; 135(3):901-10. PubMed ID: 8070385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rapid screening assay for inhibitors of 11beta-hydroxysteroid dehydrogenases (11beta-HSD): flavanone selectively inhibits 11beta-HSD1 reductase activity.
    Schweizer RA; Atanasov AG; Frey BM; Odermatt A
    Mol Cell Endocrinol; 2003 Dec; 212(1-2):41-9. PubMed ID: 14654249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 11 beta-hydroxysteroid dehydrogenases of the choriocarcinoma cell line JEG-3 and their inhibition by glycyrrhetinic acid and other natural substances.
    Gomez-Sanchez EP; Cox D; Foecking M; Ganjam V; Gomez-Sanchez CE
    Steroids; 1996 Mar; 61(3):110-5. PubMed ID: 8852827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of 11 beta-hydroxysteroid dehydrogenase in the pathogenesis of hypertension.
    van Uum SH; Hermus AR; Smits P; Thien T; Lenders JW
    Cardiovasc Res; 1998 Apr; 38(1):16-24. PubMed ID: 9683905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substrate and inhibitor specificity of the cloned human 11 beta-hydroxysteroid dehydrogenase type 2 isoform.
    Ferrari P; Smith RE; Funder JW; Krozowski ZS
    Am J Physiol; 1996 May; 270(5 Pt 1):E900-4. PubMed ID: 8967481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortisol to cortisone: glucocorticoid to mineralocorticoid.
    Stewart PM; Mason JI
    Steroids; 1995 Jan; 60(1):143-6. PubMed ID: 7792800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of dietary Na+ on glycyrrhetinic acid-like factors (kidney 11beta-(HSD2)-GALFs) in human essential hypertension.
    Morris DJ; Lo YH; Lichtfield WR; Williams GH
    Hypertension; 1998 Jan; 31(1 Pt 2):469-72. PubMed ID: 9453347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and putative role of 11 beta-hydroxysteroid dehydrogenase isozymes within the human eye.
    Rauz S; Walker EA; Shackleton CH; Hewison M; Murray PI; Stewart PM
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2037-42. PubMed ID: 11481269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 11 beta-hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotic carbonyl compounds.
    Maser E; Bannenberg G
    Biochem Pharmacol; 1994 May; 47(10):1805-12. PubMed ID: 8204097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning of the 11 beta HSD type II enzyme from human kidney.
    Albiston AL; Smith RE; Obeyesekere VR; Krozowski ZS
    Endocr Res; 1995; 21(1-2):399-409. PubMed ID: 7588404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 11 beta-Hydroxysteroid dehydrogenase antisense affects vascular contractile response and glucocorticoid metabolism.
    Souness GW; Brem AS; Morris DJ
    Steroids; 2002 Mar; 67(3-4):195-201. PubMed ID: 11856543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Licorice inhibits 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action.
    Whorwood CB; Sheppard MC; Stewart PM
    Endocrinology; 1993 Jun; 132(6):2287-92. PubMed ID: 8504732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel steroid inhibitor for a rat 20alpha-hydroxysteroid dehydrogenase isozyme.
    Yoshida S; Shiota K; Nishihara M; Takahashi M
    Biol Reprod; 1997 Dec; 57(6):1433-7. PubMed ID: 9408251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 11 beta-Hydroxysteroid dehydrogenases: key enzymes in determining tissue-specific glucocorticoid effects.
    Edwards CR; Benediktsson R; Lindsay RS; Seckl JR
    Steroids; 1996 Apr; 61(4):263-9. PubMed ID: 8733012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.